Recital 13, Regulation (EU) 2020/521

In forcesince 14 Apr 2020

In order to address supply shortages, production capacities for essential medical products such as medication, diagnostic tests, laboratory supplies, and protective gear, should be supported and funding should be provided to maintain a stock of those products.